Franklin Samuel P, Cook James L
Comparative Orthopaedic Laboratory, College of Veterinary Medicine, University of Missouri - Columbia, 379 East Campus Drive, Columbia, Missouri 65211, USA.
Can Vet J. 2013 Sep;54(9):881-4.
This prospective, randomized, double-blinded trial compared outcomes in dogs with bilateral elbow osteoarthritis (OA) treated with hyaluronan plus methylprednisolone (HA + S) or autologous conditioned plasma (ACP(®); Arthrex). An investigator blinded to the treatments graded lameness (0-4) before and 6 months after a single injection with either HA + S or ACP. Clients were blinded to treatment and completed a validated survey before and 1, 6, 12, and 24 weeks after injection. Ten dogs (5 per group) completed all parts of the study. Pre-treatment lameness grades were 1.2 ± 0.97 for HA + S and 1.8 ± 1.1 for ACP and were not different between groups. Post-treatment lameness grades were 0.4 ± 0.55 for HA + S and 0.8 ± 0.64 for ACP with significant (P < 0.05) improvement with either treatment but without differences between groups. Client-based assessments demonstrated improvements in activity, lameness, and pain with HA + S and ACP. These data suggest that both treatments have beneficial effects for dogs with bilateral elbow OA.
这项前瞻性、随机、双盲试验比较了接受透明质酸加甲基强的松龙(HA + S)或自体条件血浆(ACP(®); Arthrex公司)治疗的双侧肘关节骨关节炎(OA)犬的治疗效果。一名对治疗方案不知情的研究人员在单次注射HA + S或ACP之前及之后6个月对跛行程度进行评分(0 - 4级)。客户对治疗方案不知情,并在注射前、注射后1周、6周、12周和24周完成一份经过验证的调查问卷。10只犬(每组5只)完成了研究的所有部分。HA + S组治疗前的跛行评分为1.2±0.97,ACP组为1.8±1.1,两组之间无差异。治疗后,HA + S组的跛行评分为0.4±0.55,ACP组为0.8±0.64,两种治疗方法均有显著改善(P < 0.05),但两组之间无差异。基于客户的评估显示,HA + S和ACP治疗后犬的活动能力、跛行程度和疼痛均有所改善。这些数据表明,两种治疗方法对双侧肘关节OA犬均有有益效果。